Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-25-000026
Filing Date
2025-08-11
Accepted
2025-08-11 16:10:58
Documents
82
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20250630.htm   iXBRL 10-Q 1066450
2 EX-31.1 exhibit311-q22025.htm EX-31.1 10852
3 EX-31.2 exhibit312-q22025.htm EX-31.2 10767
4 EX-32.1 exhibit321-q22025.htm EX-32.1 5816
5 EX-32.2 exhibit322-q22025.htm EX-32.2 6045
  Complete submission text file 0001808665-25-000026.txt   6439462

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20250630.xsd EX-101.SCH 45325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20250630_cal.xml EX-101.CAL 69969
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20250630_def.xml EX-101.DEF 205442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20250630_lab.xml EX-101.LAB 576398
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20250630_pre.xml EX-101.PRE 402219
85 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20250630_htm.xml XML 951111
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 251202105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)